Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care

Research output: Contribution to journalLetter

Abstract

Soriano et al. [1] recently published data on trends in testing and diagnosis of α1-antitrypsin deficiency in chronic obstructive pulmonary disease (COPD) patients using primary care data from the UK. This was a large population-based study reporting that only ∼2.2% of patients diagnosed with COPD before the age of 60 years are tested for α1-antitrypsin deficiency and suggests that α1-antitrypsin deficiency may remain undiagnosed in many people with COPD. The study does highlight an important point that testing for this relatively rare but potentially important cause of COPD should be considered more widely among healthcare professionals.
Original languageEnglish
Article number1801986
JournalThe European respiratory journal
Volume52
Issue number6
DOIs
Publication statusPublished - 22 Dec 2018

    Fingerprint

Cite this